Change over period: —
NSE · NEOGEN
NEOGEN
-2.7% from the 52-week high · +183.8% above the low
Neogen Chemicals Ltd. engages in the manufacture of specialty chemicals which are used in pharmaceutical, engineering, and agro chemical industries. The company employs 493 full-time employees The company went IPO on 2019-05-08. The Company’s products include organic chemicals, advance intermediates, inorganic chemicals, chemistries and grignard reagents. The firm operates through three segments: organic chemicals, inorganic chemicals, and custom synthesis and manufacturing. Organic chemicals segment is involved in the manufacturing of organic bromine-based compounds, advanced intermediates, specialty compounds and Grignard reagents. The inorganic chemicals segment is involved in manufacturing inorganic lithium and bromine salts. Custom synthesis and manufacturing segment is involved in developing and manufacturing new processes and customized products.
The short version. NEOGEN reported revenue of ₹296 crore for Sep 2026, up 41.6% from a year earlier. Net profit was ₹8 crore (up 166.7% year on year). Return on equity was 3.5% in Mar 2026. Promoter holding was 48.31% in Sep 2026, down 2.91 points over 8 quarters.
1 · The price
How has the stock traded?
NEOGEN trades 2.7% below its 52-week high and 183.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹296 cr.
Sep 2026 net profit of ₹8 cr.
1.2 pts higher than a year earlier.
Revenue compounded at 7.9% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 296 | 250 | 247 | 220 | 209 | 187 | 203 | 201 |
| Net profit | 8 | 17 | 11 | 4 | 3 | 10 | 2 | 10 |
| Net margin % | 2.8 | 6.8 | 4.6 | 1.7 | 1.6 | 5.5 | 1.2 | 5.0 |
| EPS (₹) | 2.74 | 6.25 | 4.32 | 1.4 | 1.28 | 3.89 | 0.91 | 3.79 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 862 | 778 | 691 | 686 | 487 | 336 | 306 | 239 |
| Net profit | 29 | 35 | 36 | 50 | 45 | 31 | 29 | 21 |
| Net margin % | 3.3 | 4.5 | 5.2 | 7.3 | 9.2 | 9.3 | 9.4 | 8.8 |
| EPS (₹) | 10.9 | 13.2 | 13.51 | 20.04 | 17.9 | 13.43 | 12.28 | 8.98 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 3.5% in Mar 2026; debt to equity is 1.63.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 3.5 | 4.4 | 4.7 | 10.4 |
| Return on capital % | 6.8 | 9.7 | 10.1 | 15.5 |
| EBITDA margin % | 16.6 | 16.2 | 16.8 | 16.8 |
| Net margin % | 3.3 | 4.5 | 5.1 | 7.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 7.9% | 20.9% |
| Profit CAGR | -16.8% | -1.7% |
4 · The owners
Who holds it, and are they adding?
Down 2.91 pts over 8 quarters.
Down 3.22 pts over 8 quarters.
Up 0.9 pts over 8 quarters.
+11 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 51.22 | 51.22 | 51.22 | 51.22 | 51.22 | 51.22 | 53.0 | 48.31 | -2.91 |
| FII | 7.73 | 7.79 | 7.36 | 5.15 | 4.57 | 4.46 | 4.11 | 4.51 | -3.22 |
| DII | 22.53 | 22.75 | 22.96 | 25.23 | 21.99 | 22.64 | 19.6 | 23.43 | +0.9 |
| Public | 18.51 | 18.23 | 18.45 | 18.39 | 22.21 | 21.67 | 23.28 | 23.74 | +5.23 |
Mutual fund holdings · Oct 2026
36 schemes hold this stock
25 the month before.
- SAMCO SPECIAL OPPORTUNITIES FUND1.74% of NAV
- Axis Innovation Fund1.73% of NAV
- Mirae Asset Healthcare Fund1.41% of NAV
- UNION INNOVATION & OPPORTUNITIES FUND1.15% of NAV
- JM Flexi cap Fund1.03% of NAV
- ICICI Prudential Commodities Fund0.98% of NAV
- Bajaj Finserv Small Cap Fund0.9% of NAV
- Invesco India Small cap Fund0.73% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for NEOGEN are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about NEOGEN
What is the NEOGEN share price?
NEOGEN (NEOGEN) last closed at ₹2,888.50, up 3.9% on the day. Its 52-week range is ₹979.80 to ₹2,856.30.
What is the market cap of NEOGEN?
NEOGEN has a market capitalisation of about ₹8,402 crore. Its price-to-earnings ratio is 188.3.
How are NEOGEN's latest results?
NEOGEN reported revenue of ₹296 crore for Sep 2026, up 41.6% from a year earlier. Net profit was ₹8 crore (up 166.7% year on year). Return on equity was 3.5% in Mar 2026. Promoter holding was 48.31% in Sep 2026, down 2.91 points over 8 quarters.
Who owns NEOGEN?
As of Sep 2026, shareholding was: Promoter 48.31%, FII 4.51%, DII 23.43%, Public 23.74%.
How many mutual funds hold NEOGEN?
36 mutual fund schemes held NEOGEN in October 2026. That compares with 25 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 19 Sep 2025 · Final Dividend - Rs. 1
- 19 Sep 2024 · Final Dividend - Rs. 2
- 25 Aug 2023 · Final Dividend - Rs. 3
- 19 Sep 2022 · Final Dividend - Rs. 2.75
- 16 Sep 2021 · Final Dividend - Rs. 2.25
- 17 Sep 2020 · Final Dividend - Rs. 2
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.